ArticleLeukemia2025

Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.

Sameem M Abedin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.